Skip to main content

This site is intended for u.s. healthcare professionals

  • U.S. full prescribing information
REXULTI (brexpiprazole) logo

Schizophrenia (SZ)

select the Indication Schizophrenia (SZ)
  • AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER’S DISEASE
  • MAJOR DEPRESSIVE DISORDER (ADJUNCTIVE)
  • SCHIZOPHRENIA (SZ)
  • Clinical
    Pharmacology
    • Clinical Pharmacology
    • Pharmacodynamic Profile
    • Pharmacodynamics Video
  • Partial
    Response
    • Is Partial Response Good Enough?
    • Patient Profiles
  • Efficacy
    Data
    • Primary Endpoint
    • Study Design Summary
    • Additional Analysis
    • Secondary Endpoint
    • Post-hoc Analysis
  • Safety
    Profile
    • Adverse Reactions
    • Discontinuations
    • Metabolic Profile
  • Dosing &
    Titration
    • Dosing & Titration Schedule
    • Dosing Adjustments
    • Sample Starter Packs
  • Savings &
    Coverage
    • Savings Offer
    • Coverage
    • Formulary Lookup
    • Coverage Support
  • Resources
     
    • For Your Patients
    • For Your Practice
  • Efficacy
    Data
    • Short-term Efficacy
    • PANSS Total Score: Disease Severity
    • Maintenance Efficacy Data
  • Safety
    Profile
    • Adverse Reactions
    • Additional Safety
    • Metabolic Profile
  • Patient
    Profile
  • Clinical
    Pharmacology
  • Dosing &
    Titration
    • Dosing & Titration Schedule
    • Dosing Adjustments
    • Sample Starter Packs
  • Savings &
    Coverage
    • Savings Offer
    • Coverage
    • Formulary Lookup
    • Coverage Support
  • Resources
     
    • For Your Patients
    • For Your Practice
  • Symptoms
  • Efficacy
    Data
    • Primary Endpoint
    • Full Study Design
    • Secondary Endpoint
    • CMAI Scale
  • Safety
    Profile
    • Adverse Reactions
    • Discontinuations
    • Extension
  • Dosing &
    Titration
    • Dosing & Titration Schedule
    • Dose Adjustments
  • Patient/Caregiver
    Profiles
  • Clinical
    Pharmacology
  • Savings &
    Coverage
    • Coverage
    • Formulary Lookup
    • Coverage Support
    • Savings Offer
  • Resources
    • For Your Patients and Caregivers
    • For Your Practice
  • Request a Rep
  • Find Speaker Programs
  • For Patients AND& Caregivers
select the Indication Schizophrenia (SZ)
  • AGITATION ASSOCIATED WITH DEMENTIA DUE TO ALZHEIMER’S DISEASE
  • MAJOR DEPRESSIVE DISORDER (ADJUNCTIVE)
  • SCHIZOPHRENIA (SZ)
  • Clinical
    Pharmacology
    • Clinical Pharmacology
    • Pharmacodynamic Profile
    • Pharmacodynamics Video
  • Partial
    Response
    • Is Partial Response Good Enough?
    • Patient Profiles
  • Efficacy
    Data
    • Primary Endpoint
    • Study Design Summary
    • Additional Analysis
    • Secondary Endpoint
    • Post-hoc Analysis
  • Safety
    Profile
    • Adverse Reactions
    • Discontinuations
    • Metabolic Profile
  • Dosing &
    Titration
    • Dosing & Titration Schedule
    • Dosing Adjustments
    • Sample Starter Packs
  • Savings &
    Coverage
    • Savings Offer
    • Coverage
    • Formulary Lookup
    • Coverage Support
  • Resources
     
    • For Your Patients
    • For Your Practice
  • Efficacy
    Data
    • Short-term Efficacy
    • PANSS Total Score: Disease Severity
    • Maintenance Efficacy Data
  • Safety
    Profile
    • Adverse Reactions
    • Additional Safety
    • Metabolic Profile
  • Patient
    Profile
  • Clinical
    Pharmacology
  • Dosing &
    Titration
    • Dosing & Titration Schedule
    • Dosing Adjustments
    • Sample Starter Packs
  • Savings &
    Coverage
    • Savings Offer
    • Coverage
    • Formulary Lookup
    • Coverage Support
  • Resources
     
    • For Your Patients
    • For Your Practice
  • Symptoms
  • Efficacy
    Data
    • Primary Endpoint
    • Full Study Design
    • Secondary Endpoint
    • CMAI Scale
  • Safety
    Profile
    • Adverse Reactions
    • Discontinuations
    • Extension
  • Dosing &
    Titration
    • Dosing & Titration Schedule
    • Dose Adjustments
  • Patient/Caregiver
    Profiles
  • Clinical
    Pharmacology
  • Savings &
    Coverage
    • Coverage
    • Formulary Lookup
    • Coverage Support
    • Savings Offer
  • Resources
    • For Your Patients and Caregivers
    • For Your Practice
Skip to Important Safety Information
Dosing & Titration Schedule
Dosing & Titration Schedule Dosing Adjustments Sample Starter Packs

Dosing information for REXULTI® (brexpiprazole) in adults and pediatric patients 13+ with schizophrenia

Dosing and titration schedule

REXULTI—recommended target dose: 2 mg/day to 4 mg/day